Telemedicine follow-up of hospitalized patients with coronavirus disease-2019 (COVID-19).
- Conditions
- U07.1COVID-19, virus identified
- Registration Number
- DRKS00022244
- Lead Sponsor
- Charité - Universitätsmedizin Berlin CharitéCentrum 11 für Herz-Kreislauf-Medizin Arbeitsbereich Kardiovaskuläre Telemedizin
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 113
Inclusion Criteria
1.Hospitalization with detection of SARS-CoV-2 RNA (PCR) in naso-/oropharyngeal swab (hospital discharge letter available).
2.age of majority
3.written informed consent of the patient
Exclusion Criteria
1.inability or unwillingness to measure daily vital signs (e.g., dementia, blindness, deafness, wheelchair use, inadequate German language skills, speech or voice disorders that interfere with voice analysis, limited informal self-determination)
2.participation in therapy studies (observational studies and registries are possible).
Study & Design
- Study Type
- observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method umber of unplanned clinical events (emergency telemedicine interventions, emergency department presentations, unplanned hospitalizations, death from any cause) as a composite endpoint during 1 year of telemedicine follow-up of hospitalized COVID-19- patients.
- Secondary Outcome Measures
Name Time Method 1.Days lost due to unplanned hospitalizations and death from any cause during one-year follow-up.<br>2.total mortality<br>3.number of unplanned hospitalizations<br>4.number of emergency department presentations<br>5.Number of telemedicine interventions for emergencies<br>6.changes in quality of life during follow-up <br>7.number of TMZ-contacts to the patient due to abnormal telemonitoring findings. <br>8.number of TMZ contacts to primary care physicians due to abnormal telemonitoring findings<br>9.adherence to telemonitoring